Author:
Giant Tibor T.,Mikecz Katalin,Bartlett Robert R.,Deák Ferenc,Thonar Eugene J.-M.A.,Williams James M.,Mattar Thomas,Kuettner Klaus E.,Schleyerbach Rudolf
Reference30 articles.
1. immunophannacological profile of HWA 486, a novel isoxazol derivative. II. In vivo imniunomodulating effects differ from those of cyclophosphamide, prednisolone, or cyclosporin A;Bartlett;Int J Immunophar,1986
2. (HWA 486), a novel immuno-modulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection;Bartlett;Agents Actions,1991
3. (HWA 486): a novel immunorestoring drug;Bartlett,1989
4. Development of autoimmunity in MRL/lpr mice and the effect of drugs on this murine disease;Bartlett;Scand J Rheumatol,1988
5. Immunophannacological profile of a novel isoxazol derivative. HWA 486, with potential antirheumatic activity. I. Disease modifying action on adjuvant arthritis of the rat;Bartlett;Int J Immunophannacol,1985
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. JAK Inhibitors in Rheumatoid Arthritis: Immunomodulatory Properties and Clinical Efficacy;International Journal of Molecular Sciences;2024-07-30
2. Methods for Testing Immunological Factors;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2024
3. The use of animal models in rheumatoid arthritis research;Journal of Yeungnam Medical Science;2023-01-31
4. Methods for Testing Immunological Factors;Drug Discovery and Evaluation: Pharmacological Assays;2016
5. Methods for Testing Immunological Factors;Drug Discovery and Evaluation: Pharmacological Assays;2015